Eculizumab and Beyond: The Past, Present, and Future of Complement Therapeutics
Christopher J. Patriquin(University Health Network), Kevin H.M. Kuo(University Health Network)
Cited by 67
Related Papers
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
|New England Journal of Medicine|2020|320
Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study
|Blood|2018|165
Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency
|New England Journal of Medicine|2019|162
Prophylactic transfusion for pregnant women with sickle cell disease: a systematic review and meta-analysis
|Blood|2015|129
Depression, Depression Treatments, and Risk of Incident Dementia: A Prospective Cohort Study of 354,313 Participants
|Biological Psychiatry|2022|113